The European Paediatric Medicines Database (EPMD) has been set up by TEDDY Network, with the aim of creating a harmonised, integrated and reliable pan-European source of information.
The data stored in this database is the basis for examining the ‘state of the art’ of paediatric innovative medicines licensed by the European Medicines Agency (EMA) from October 1995.
This database represents a valid tool to share knowledge concerning the innovative drugs currently used in children and support health professionals, paediatricians, institutional bodies, companies, patients’ associations, parents and children with appropriate information concerning the rational use of paediatric medicines as well as promote the transparency of the information.
The analysis of the information stored in the EPMD allows the identification of therapeutic areas uncovered by innovative drug treatments and provides.
For all paediatric medicines registered in Europe under the EMA Centralised Procedure, the EPMD includes information on: year of approval, active substance, tradename, Anatomical Therapeutic Chemical (ATC) code – first-level, paediatric indication, ages for which the drug is intended, orphan status, paediatric studies included in the EPAR at the time of approval.
To date the database contains a total of 411 medicinal products, including vaccines, corresponding to 256 different active substances.
The database is available at this link.